EcoDrugPlus

Tyrosinase

Ensembl ID : ENSCLAG00000016284
Gene Symbol: TYR
3 Cross references
266 Possible Orthologues:

Tyrosine Hydroxylase

Ensembl ID : ENSCLAG00000015576
Gene Symbol: TH
3 Cross references
188 Possible Orthologues:

Tyrosine Kinase 2

Ensembl ID : ENSCLAG00000013417
Gene Symbol: TYK2
2 Cross references
197 Possible Orthologues:

Tyrosine Kinase With Immunoglobulin Like And Egf Like Domains 1

Ensembl ID : ENSCLAG00000004371
Gene Symbol: TIE1
3 Cross references
205 Possible Orthologues:

Utrophin

Ensembl ID : ENSCLAG00000014075
Gene Symbol: UTRN
3 Cross references
268 Possible Orthologues:

Vascular Endothelial Growth Factor A

Ensembl ID : ENSCLAG00000014201
Gene Symbol: VEGFA
1 Cross references
254 Possible Orthologues:

Vitamin D Receptor

Ensembl ID : ENSCLAG00000007173
Gene Symbol: VDR
3 Cross references
466 Possible Orthologues:

Vitamin K Epoxide Reductase Complex Subunit 1

Ensembl ID : ENSCLAG00000012539
Gene Symbol: VKORC1
1 Cross references
190 Possible Orthologues:

Ensembl ID : ENSCLAG00000000639
Gene Symbol: -
Cross references: -
199 Possible Orthologues:

Ensembl ID : ENSCLAG00000011150
Gene Symbol: -
Cross references: -
196 Possible Orthologues:

Ensembl ID : ENSCLAG00000003083
Gene Symbol: -
Cross references: -
194 Possible Orthologues:

Ensembl ID : ENSCLAG00000016584
Gene Symbol: -
Cross references: -
187 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).